(VIANEWS) - Zynex (ZYXI), Perion Network Ltd (PERI), BioDelivery Sciences International (BDSI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Zynex (ZYXI)
54.3% sales growth and 17% return on equity
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation.
Zynex's sales growth this year is anticipated to be 63.8% and 38.1% for next year.
Year-on-year quarterly revenue growth grew by 73.7%, now sitting on 115.54M for the twelve trailing months.
Volume
Today's last reported volume for Zynex is 1589240 which is 326.44% above its average volume of 372676.
Zynex's sales growth for the next quarter is 54.3%. The company's growth estimates for the ongoing quarter and the next is 280% and 450%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17%.
Volatility
Zynex's last day, last week, and last month's current intraday variation average was 9.90%, 6.92%, and 3.83%, respectively.
Zynex's highest amplitude of average volatility was 25.62% (day), 13.42% (last week), and 7.64% (last month), respectively.
Zynex's Stock Yearly Top and Bottom Value
Zynex's stock is valued at $6.77 at 15:22 EST, way below its 52-week high of $17.32 and way higher than its 52-week low of $5.62.
Zynex's Moving Average
Zynex's value is way under its 50-day moving average of $8.37 and way under its 200-day moving average of $11.62.2. Perion Network Ltd (PERI)
34.4% sales growth and 11.89% return on equity
Perion Network Ltd.
Perion Network Ltd's sales growth this year is anticipated to be 29.3% and 15.5% for next year.
Year-on-year quarterly revenue growth grew by 33.6%, now sitting on 478.5M for the twelve trailing months.
Volume
Today's last reported volume for Perion Network Ltd is 421018 which is 39.88% below its average volume of 700360.
Perion Network Ltd's sales growth for the next quarter is 34.4%. The company's growth estimates for the ongoing quarter and the next is 200% and 78.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.89%.
Volatility
Perion Network Ltd's last day, last week, and last month's current intraday variation average was 1.37%, 3.23%, and 4.09%, respectively.
Perion Network Ltd's highest amplitude of average volatility was 4.61% (day), 6.73% (last week), and 6.56% (last month), respectively.
Perion Network Ltd's Stock Yearly Top and Bottom Value
Perion Network Ltd's stock is valued at $22.56 at 15:22 EST, way under its 52-week high of $33.09 and way higher than its 52-week low of $13.75.
Perion Network Ltd's Moving Average
Perion Network Ltd's value is above its 50-day moving average of $21.61 and above its 200-day moving average of $20.88.3. BioDelivery Sciences International (BDSI)
20.1% sales growth and 28.51% return on equity
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally.
BioDelivery Sciences International's sales growth this year is anticipated to be 5.7% and 25.8% for next year.
Year-on-year quarterly revenue growth grew by 4.2%, now sitting on 165.72M for the twelve trailing months.
Volume
Today's last reported volume for BioDelivery Sciences International is 2469390 which is 16.43% below its average volume of 2954950.
BioDelivery Sciences International's sales growth for the next quarter is 20.1%. The company's growth estimates for the ongoing quarter and the next is a negative 90% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.51%.
Volatility
BioDelivery Sciences International's last day, last week, and last month's current intraday variation average was 0.36%, 0.22%, and 3.20%, respectively.
BioDelivery Sciences International's highest amplitude of average volatility was 0.36% (day), 0.47% (last week), and 2.29% (last month), respectively.
BioDelivery Sciences International's Stock Yearly Top and Bottom Value
BioDelivery Sciences International's stock is valued at $5.55 at 15:22 EST, under its 52-week high of $5.58 and way higher than its 52-week low of $2.50.
BioDelivery Sciences International's Moving Average
BioDelivery Sciences International's worth is way higher than its 50-day moving average of $3.70 and way above its 200-day moving average of $3.64.4. Shutterstock (SSTK)
17.5% sales growth and 20.64% return on equity
Shutterstock, Inc., a technology company, provides content, and tools and services in North America, Europe, and internationally.
Shutterstock's sales growth this year is expected to be 9.1% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 773.41M for the twelve trailing months.
Volume
Today's last reported volume for Shutterstock is 41095 which is 84.87% below its average volume of 271761.
Shutterstock's sales growth for the next quarter is 17.5%. The company's growth estimates for the current quarter and the next is a negative 12.2% and negative -6.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.64%.
Volatility
Shutterstock's last day, last week, and last month's current intraday variation average was 5.56%, 2.96%, and 2.93%, respectively.
Shutterstock's highest amplitude of average volatility was 10.45% (day), 5.93% (last week), and 5.22% (last month), respectively.
Shutterstock's Stock Yearly Top and Bottom Value
Shutterstock's stock is valued at $89.36 at 15:22 EST, way below its 52-week high of $128.36 and way above its 52-week low of $77.38.
Shutterstock's Moving Average
Shutterstock's worth is below its 50-day moving average of $97.92 and way under its 200-day moving average of $105.19.5. Intuitive Surgical (ISRG)
14% sales growth and 12.67% return on equity
Intuitive Surgical, Inc., together with its subsidiaries, designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally.
Intuitive Surgical's sales growth this year is anticipated to be 29.5% and 13.1% for next year.
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 4.55B for the twelve trailing months.
Volume
Today's last reported volume for Intuitive Surgical is 1119370 which is 44.4% below its average volume of 2013530.
Intuitive Surgical's sales growth for the next quarter is 14%. The company's growth estimates for the present quarter and the next is 26.7% and 4.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.67%.
Volatility
Intuitive Surgical's last day, last week, and last month's current intraday variation average was 0.42%, 2.06%, and 1.76%, respectively.
Intuitive Surgical's highest amplitude of average volatility was 2.36% (day), 4.10% (last week), and 3.14% (last month), respectively.
Intuitive Surgical's Stock Yearly Top and Bottom Value
Intuitive Surgical's stock is valued at $299.46 at 15:22 EST, under its 52-week low of $313.69.
Intuitive Surgical's Moving Average
Intuitive Surgical's value is way below its 50-day moving average of $342.54 and way under its 200-day moving average of $730.36.6. Luxfer Holdings PLC (LXFR)
13.5% sales growth and 18.22% return on equity
Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications.
Luxfer Holdings PLC's sales growth this year is expected to be 12.5% and 6.5% for next year.
Year-on-year quarterly revenue growth grew by 17.4%, now sitting on 357.5M for the twelve trailing months.
Volume
Today's last reported volume for Luxfer Holdings PLC is 356638 which is 350.4% above its average volume of 79181.
Luxfer Holdings PLC's sales growth for the next quarter is 13.5%. The company's growth estimates for the present quarter and the next is a negative 14.8% and negative -17.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.22%.
Volatility
Luxfer Holdings PLC's last day, last week, and last month's current intraday variation average was 3.83%, 2.37%, and 1.70%, respectively.
Luxfer Holdings PLC's highest amplitude of average volatility was 4.02% (day), 4.21% (last week), and 4.38% (last month), respectively.
Luxfer Holdings PLC's Stock Yearly Top and Bottom Value
Luxfer Holdings PLC's stock is valued at $15.99 at 15:22 EST, way under its 52-week high of $23.91 and above its 52-week low of $15.34.
Luxfer Holdings PLC's Moving Average
Luxfer Holdings PLC's value is way below its 50-day moving average of $17.85 and way below its 200-day moving average of $20.25.7. LeMaitre Vascular (LMAT)
10.5% sales growth and 13.54% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide.
LeMaitre Vascular's sales growth this year is expected to be 19.7% and 7.8% for next year.
Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 152.47M for the twelve trailing months.
Volume
Today's last reported volume for LeMaitre Vascular is 180845 which is 95.64% above its average volume of 92436.
LeMaitre Vascular's sales growth for the next quarter is 10.5%. The company's growth estimates for the current quarter and the next is a negative 8.8% and 7.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.54%.
Volatility
LeMaitre Vascular's last day, last week, and last month's current intraday variation average was 2.13%, 2.36%, and 1.80%, respectively.
LeMaitre Vascular's highest amplitude of average volatility was 4.36% (day), 5.19% (last week), and 3.91% (last month), respectively.
LeMaitre Vascular's Stock Yearly Top and Bottom Value
LeMaitre Vascular's stock is valued at $47.47 at 15:22 EST, way below its 52-week high of $64.50 and way above its 52-week low of $39.48.
LeMaitre Vascular's Moving Average
LeMaitre Vascular's worth is higher than its 50-day moving average of $45.62 and under its 200-day moving average of $52.33.8. American Software (AMSWA)
9.3% sales growth and 9.38% return on equity
American Software, Inc. develops, markets, and supports a range of computer business application software products and services in the United States and internationally.
American Software's sales growth this year is expected to be 9.2% and 8.2% for next year.
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 116.73M for the twelve trailing months.
Volume
Today's last reported volume for American Software is 121771 which is 5.59% above its average volume of 115320.
American Software's sales growth is a negative 0% for the present quarter and 9.3% for the next. The company's growth estimates for the current quarter and the next is a negative 22.2% and negative -27.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.38%.
Volatility
American Software's last day, last week, and last month's current intraday variation average was 2.95%, 4.34%, and 2.48%, respectively.
American Software's highest amplitude of average volatility was 4.06% (day), 6.69% (last week), and 4.46% (last month), respectively.
American Software's Stock Yearly Top and Bottom Value
American Software's stock is valued at $22.00 at 15:22 EST, way below its 52-week high of $33.27 and way above its 52-week low of $18.41.